	High TROP-2 expression as a predictor of poor neoadjuvant chemotherapy response in luminal B breast cancer: a retrospective clinicopathological study. BMC Cancer Öztürk Ç, Çubukçu SS, , Öztürk AE, Okcu O. PMID: 42177446 [PubMed - as supplied by publisher]
	WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design. NPJ Breast Cancer Fiscalini A, Blum K, Fergus K, Hiatt RA, Naeim A, Kaster A, Scheuner MT, van 't Veer LJ, LaCroix AZ, Borowsky AD, Olopade OI, Park HL, Esserman J, Lancaster R, Heditsian D, Brain S, Lee V, Goodman DL, Ross KS, Wenger N, Parker BA, Madlensky L, Tice JA, Shieh Y, Ziv E, Arasu VA, Anton-Culver H, Kaplan CP, Rhoads KF, Badal K, Hogarth M, Petruse A, Soto IA, Leggat-Barr K, Goodman S, Atamer J, Ryu R, Adduci K, Matthews JB, Eklund M, Athena/WISDOM Network Collaborators and Advocate Partners, Sabacan LP, Esserman L. PMID: 42177197 [PubMed - as supplied by publisher]
	A case-control study of the association between per- and polyfluoroalkyl substances (PFAS) and risk of postmenopausal breast cancer in the Danish Diet Cancer and Health cohort. Environ Res Jensen TK, Hvidtfeldt UA, Tjønneland A, Batzella E, Nielsen F, Raaschou-Nielsen O. PMID: 42176938 [PubMed - as supplied by publisher]
	Urinary melatonin: A non-invasive breast cancer biomarker. Clin Chim Acta Khan A, Alhuthali HM, Alzahrani S, Alrehaili AA, Alharthi NS, Singla N, Rehman ZU, Imran M. PMID: 42176935 [PubMed - as supplied by publisher]
	Digital twins for non-invasive tumor localization in breast-conserving surgery: a technical pilot study. Breast Timóteo R, Laborde A, Vaz B, Loução N, Forghani Y, Cardoso A, Correia M, Santinha J, Simões Lopes D, Marques T, Gouveia P. PMID: 42176684 [PubMed - as supplied by publisher]
	CADD-based discovery of novel heterocyclic pyrimidine-based CDK4/6 inhibitors: Design, synthesis, and anti-breast cancer activity studies. Eur J Med Chem Lv X, Huang X, Tian L, Xu S, Zhan Y, Hou H, Zhang D, Wang L, Xu S. PMID: 42176658 [PubMed - as supplied by publisher]
	The rise of selective estrogen receptor modulators (SERMs) in breast cancer therapy: a promising horizon. Cancer Treat Res Commun Al-Zoubi RM, Garada K, Zarour AA, Elaarag M, Farhan A, Al-Hurani EA, Al-Zoubi SR, Fares ZE, Al-Qudimat AR, Zoubi MSA, Bawadi H, Zakaria ZZ, Agouni A, Alrumaihi K. PMID: 42176550 [PubMed - as supplied by publisher]
	Optimization of CBCT-guided imaging schedules for left-sided postmastectomy radiotherapy using VMAT: A dosimetric, radiobiological, and cost analysis. J Appl Clin Med Phys Liu D, Lu C, Zou X, Liu L, Liu L, Zhou L. PMID: 42176309 [PubMed - indexed for MEDLINE]
	Doxorubicin-Induced Cardiotoxicity in Breast Cancer: Mechanistic Pathways, Pharmacogenomic Modifiers, and Translational Strategies. Cardiovasc Toxicol Kuok CT, Lee HW, Huang CY, Cheng YC, Lin SC, Guo JW. PMID: 42176227 [PubMed - indexed for MEDLINE]
	Prevalence of preoperative multidimensional frailty and associated factors in middle-aged and older patients with newly diagnosed breast cancer: a cross-sectional study. Support Care Cancer Cheng W, Zhang B, Zhang Y, Fang J, Yan J, He H, Chen L, Zhang N, Zhang Y, Zhang M. PMID: 42176214 [PubMed - indexed for MEDLINE]
	Prognosis of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, 1-3 node-positive breast cancer meeting the high-risk criteria of the monarchE trial: a comparison between macrometastasis and micrometastasis. Breast Cancer Murata T, Yoshida M, Watase C, Maeda H, Nakashoji A, Ogawa A, Ohgi N, Chen M, Tsubota S, Maeshima A, Iwamoto E, Takayama S. PMID: 42176177 [PubMed - as supplied by publisher]
	Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness). Breast Cancer Taji T, Uemura Y, Kimura Y, Maeda N, Ito A, Seki H, Takabatake D, Harao M, Nakamoto S, Matsunuma R, Koganezawa C, Iwamoto T, Mukai H, Kikawa Y. PMID: 42176176 [PubMed - as supplied by publisher]
	Changes in facial emotion processing and depression and anxiety symptoms with polycystic ovary syndrome treatment: a longitudinal, naturalistic study. Arch Womens Ment Health Douglas KM, Sukhapure M, Porter RJ, Fenton A, Eggleston K. PMID: 42176072 [PubMed - indexed for MEDLINE]
	Reprogramming the Immune Landscape of Inflammatory Breast Cancer. Adv Sci (Weinh) Martinez-Rodriguez V, Ogata S, Wang X, Ueno NT. PMID: 42175736 [PubMed - as supplied by publisher]
	A Cross-Level Diary Study of Psychological Flexibility and Its Effects on Self-Esteem and Negative Emotional Dynamics in Women Survivors of Breast Cancer. Psychooncology Carmona-Cobo I, Ballesteros MM, Camilo C, Lima ML. PMID: 42175612 [PubMed - indexed for MEDLINE]
	Duodenal metastasis from endometrial cancer: A rare metastatic site, a case report and literature review. Womens Health (Lond) Sakhri S, Rahmouni E, Abidi F, Houcine Y, Dhiab TB. PMID: 42175552 [PubMed - indexed for MEDLINE]
	Impact of diabetes on breast cancer mortality in elderly female patients: A retrospective analysis (1999-2020). Medicine (Baltimore) Bin Gulzar AH, Ratan P, Faizan A, Waqar K, Riaz A, Khaskheli FI, Brohi F, Khan AH, Zaka S, Shahid A, Ali BA, Bibi M, Ahmed MA, Cheema AAA. PMID: 42175463 [PubMed - indexed for MEDLINE]
	Personalizing Breast Cancer Care Through a Patient Portal and EHR-Integrated Decision Support Tool. Stud Health Technol Inform Salwei ME, Voigtman B, Faiman J, Reale C, Myles R, Beebe R, McCoy AB, Weinger MB. PMID: 42175293 [PubMed - indexed for MEDLINE]
	How Good Are Patient-Facing LLMs at Survivorship Questions? A Comparative User Evaluation Across Four Chatbots. Stud Health Technol Inform Khairat S, Masoumi S, Mehraby H, Geracitano J. PMID: 42175007 [PubMed - indexed for MEDLINE]
	A Real-Time Clinical Text Information Extractor via LLM. Stud Health Technol Inform Tobia GP, Tomassini F, Criscione M, Dachena C, Luraschi A, Rosati A, Fagotti A, Bernaschi M, Patarnello S, Lilli L. PMID: 42174977 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 329115

Page 1 of 16456



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy